Home
News
Tech
Finance
Leadership
Well
Recommends
Fortune 500

Already have an account?

Sections

FORTUNE 500
News
Tech

A.I.

Finance

Personal Finance
Real Estate
Crypto

Leadership

Success

Well

Life
Health
Mind
Family
Aging Well

Recommends

Credit Cards
Banking
Insurance
Mortgages
Investing
Loans

Education
Video

Rankings

FORTUNE 500
GLOBAL 500
MOST POWERFUL WOMEN
GREAT PLACE TO WORK LISTS
BEST MBA PROGRAMS
MORE RANKINGS

Analytics
Newsletters
Magazine

August/September 2023
June/July 2023
April/May 2023
February/March 2023
December 2022/January 2023

Live Media
Connect

e-Cigarettes

Health FDA slams the most popular disposable e-cigarette in U.S. as ‘addicting our nation’s youth’ and warns stores to stop selling it
BYMatthew Perrone and The Associated Press
Health America’s adult smoking rate just hit an all-time low in 2022
BYMike Stobbe and The Associated Press
Retail Altria tries to ‘responsibly accelerate U.S. adult smoker and competitive adult vaper adoption’ with $2.75 billion investment in NJOY
BYMichelle Chapman and The Associated Press
Health Juul to pay nearly $440 million to settle states’ investigation into marketing of its e-cigarettes to teens
BYMatthew Perrone, Dave Collins, and others
Retail Juul e-cigs are already back on shelves
BYChris Morris
Health FDA bans Juul e-cigarettes amid spike in teen vaping
BYMatthew Perrone and The Associated Press

Politics Juul e-cigs could be taken off the market as early as today
BYChris Morris
Health Teen vaping dropped during the pandemic—will it last?
BYKat Eschner
Leadership Philip Morris CEO aims for a ‘smoke-free future’
BYSusie Gharib
Retail Vaping Industry Gets a Minty Respite From Trump’s Flavor Ban
BYMatthew Perrone and The Associated Press
Newsletters A New Study Shows the Damage Just 3 Years of Vaping Could Do to Your Lungs
BYSy Mukherjee
Health Trump’s New FDA Nominee Advances in the Senate—But Faces Tough Questions About Vaping
BYSy Mukherjee
Newsletters The Sordid Tale of Juul
BYAlan Murray and David Meyer
Politics Slashing Cigarette Nicotine Levels No Longer on FDA’s Agenda
BYDrew Armstrong and Bloomberg
Newsletters CDC Homes In on the Chemical Villain Causing Mysterious Vaping Illnesses
BYSy Mukherjee

Rankings

40 Under 40
100 Best Companies
Fortune 500
Global 500

Most Powerful Women
World’s Greatest Leaders
World’s Most Admired Companies
See All Rankings

Sections

Finance
Leadership
Success
Tech

Asia
Europe
Environment
Fortune Crypto

Health
Well
Retail
Lifestyle
Politics

Newsletters
Magazine
Features
Commentary

MPW
Conferences
Personal Finance
Recommends

Customer Support

Frequently Asked Questions
Customer Service Portal
Privacy Policy
Terms of Use
Single Issues for Purchase
International Print

Commercial Services

Fortune Brand Studio
Fortune Analytics
Fortune Conferences
Advertising
Business Development

About Us

About Us
Editorial Calendar
Work at Fortune
Behavioral Advertising Notice
Terms and Conditions
Site Map

© 2023 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information | Ad Choices
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.